Bone mineral density and vitamin D in patients with sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 16, Issue 2, 1999, Pages 219-223

  Hamada, Kunio ^a   Nagai, Sonoko ^a   Tsutsumi, Takeo ^b   Izumi, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Bone mineral density; Calcium metabolism; Sarcoidosis; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM ION; CORTICOSTEROID; OSTEOCALCIN; VITAMIN D;

ADULT; AGE; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LUMBAR VERTEBRA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADULT; AGE FACTORS; BONE DENSITY; CALCIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS; SEX FACTORS; VITAMIN D;

EID: 0032862921     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Stern PH, De-Olazabal J, Bell NH: Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest 1980; 66: 852-855.
2. Zerwekh JE, Pak CY, Kaplan RA et al: Pathogenetic role of 1 alpha, 25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. J Clin Endocrinol Metab 1980; 51: 381-386.
3. Adams JS, Gacad MA: Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 1985; 161: 755-765.
4. Hamada K, Nagai S, Tsutsumi T, Izumi T: Ionized calcium and 1,25-Dihydroxyvitamin D concentration in serum of patients with sarcoidosis. Eur Respir J 1998; 11: 1015-1020.
5. Montagnani M, Gonnelli S, Zacchei F et al: Calcium-phosphorus metabolism in sarcoidosis. Sarcoidosis 1993; 10: 150-151.
6. Rottoli P, Gonnelli S, Silitro S et al: Alterations in calcium metabolism and bone mineral density in relation to the activity of sarcoidosis. Sarcoidosis 1993; 10: 161-162.
7. Montemurro L, Fraioli P, Rizzato G: Bone loss in untreated longstanding sarcoidosis. Sarcoidosis 1991; 8: 29-34.
8. Buchanan JR, Santen R, Cauffman S, Cavaliere A, Greer RB, Demers LM: The effect of endogenous estrogen fluctuation on metabolism of 25-Hydroxyvitamin D. Calcif Tissue Int 1986; 39: 139-144.
9. Szulc MC, Chapuy MC, Meunier J: Serum undecarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769-1774.
10. Amento EP, Bhalla AK, Kurnick JT et al: 1 alpha, 25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest 1984; 73: 731-739.
11. Rigby WF, Shen L, Ball ED, Guyre PM, Fanger MW: Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood 1984; 64: 1110-1115.
12. Abu-Amer Y, Bar-Shavit Z: Impaired bone marrow-derived macrophage differentiation in vitamin D deficiency. Cell Immunol 1987; 151: 356-368.
13. Lomri A, Baron R: 1 alpha, 25-dihydroxyvitamin D3 regulates the transcription of carbonic anhydrase II mRNA in avian myelomonocytes. Proc Natl Acad Sci USA 1992; 89: 4688-4692.
14. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA: The human osteoclast precursor circulates in the monocytes fraction. Endocrinology 1996; 137: 4058-4060.
15. Nagai S, Izumi T: Pulmonary sarcoidosis: population differences and pathophysiology. South Med J 1995; 88: 1001-1010.
16. Sharma O: Vitamin D, calcium, and sarcoidosis. Chest 1996; 109: 535-539.
17. Chapuy MC, Arlot ME, Duboeuf F et al: Vitamin D3 and calcium to prevent hip fractures in the elderly women N Engl J Med 1992; 327: 1637-1642.
18. Sirtori P, Sosio C, Resmini G, Rubinacci A: Effect of short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodelling in postmenopausal women. Pharmacol Res 1996; 33: 353-359.